Our results were consistent with previous study indicating that CD47 was regulated by sets of pro-inflammatory super-enhancers in breast cancer, diffuse large B-cell lymphoma and acute lymphoblastic leukemia [40]. This evidence concerns the gene CD47 and breast carcinoma.